Mei, C., Xu, G., Zheng, C., Xie, Y., Li, M., Shao, Y., Yao, R., Tao, S., Jiang, W., Guo, J., Zheng, Z., Wang, W., Zhou, X., Ma, L., Ye, L., Luo, Y., Yang, C., Yu, W., Xie, W., Jin, J. and Tong, H. (2020) “Recombinant human erythropoietin plus all-trans retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trial”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2024.287055.